Koelis Announces New Products at American Urology Association (“AUA”) Meeting
May 11, 2022 08:00 ET
|
Koelis
GRENOBLE, France and PRINCETON, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in the care of prostate cancer, announced today...
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
October 27, 2021 02:15 ET
|
Curium
St. Louis, MO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Curium announced today that the Company has received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin its Phase 3...
AB Science annonce que les résultats de l'étude AB12003 du masitinib dans le cancer de la prostate ont été présentés lors du congrès annuel 2021 de l'American Urological Association
September 13, 2021 12:04 ET
|
AB Science
COMMUNIQUE DE PRESSE LES RESULTATS DE L’ETUDE AB12003 DU MASITINIB DANS LE CANCER DE LA PROSTATE ONT ETE PRESENTES LORS DU CONGRES ANNUEL DE L’AMERICAN UROLOGICAL ASSOCIATION ET ONT ETE PUBLIES DANS...
AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association
September 13, 2021 12:04 ET
|
AB Science
PRESS RELEASE RESULTS FROM MASITINIB STUDY AB12003 IN PROSTATE CANCER PRESENTED AT THE AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING WITH ABSTRACT PUBLISHED IN JOURNAL OF UROLOGY Paris, 13...
ProstaMend Reviews: Negative Side Effects or Real Prostate Pills? 2021 Review
March 12, 2021 13:41 ET
|
2021Review.com
Chicago, March 12, 2021 (GLOBE NEWSWIRE) -- ProstaMend is a daily prostate supplement that reduces its size and helps consumers reduce the number of times they go to the bathroom throughout their...
Shedir Pharma, an Italian Health and Wellness Company, Develops Nutritional Supplement for Prostate Functionality
December 27, 2019 10:40 ET
|
Shedir Pharma
BOCA RATON, FL, Dec. 27, 2019 (GLOBE NEWSWIRE) -- If a man lives long enough, he will probably have prostate issues. Millions of men, especially those over 50, have enlarged prostates. Prostate...
Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction
November 28, 2018 04:00 ET
|
Surgical Lasers Inc.
TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aquarius Surgical Technologies Inc. (ASTI – CSE) (“the Corporation”) is pleased to announce that Mr. Gordon Willox, has been appointed to the position of...
Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA
May 17, 2018 12:47 ET
|
Exosome Diagnostics
Waltham, MA, May 17, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics’ novel urine-based prostate cancer liquid biopsy biomarker test, ExoDx™ Prostate(IntelliScore) or EPI, was selected out of 3000...